Literature DB >> 13160265

Ethaverine in the treatment of angina pectoris.

D P DEGENHARDT, R HODGKINSON.   

Abstract

Entities:  

Keywords:  ANGINA PECTORIS/therapy; MUSCLE RELAXANTS/therapeutic use

Mesh：

Substances：

Year:  1954        PMID： 13160265      PMCID： PMC479509          DOI： 10.1136/hrt.16.2.142

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  7 in total

1.  Pharmacologic studies of 6,7-dimethoxy-1-(4'-ethoxy-3'-methoxy-benzyl)-3-methyl-isoquinoline.

Authors:  F G HENDERSON; R E SHIPLEY; K K CHEN
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1951-04

2.  Effects of dioxyline phosphate and enteric-coated khellin on coronary artery insufficiency.

Authors:  M M BEST; W S COE
Journal:  Am J Med Sci       Date:  1951-07       Impact factor: 2.378

3.  Evaluation of paveril in angina pectoris.

Authors:  R A FRISCH; K K KAUFMAN; R BEEZY; M W GARRY
Journal:  Am J Med Sci       Date:  1952-09       Impact factor: 2.378

4.  Anginal relief with paveril phosphate.

Authors:  J M MEYER; H L CORRELL; B J PETERS; M C F LINDERT
Journal:  Am Pract Dig Treat       Date:  1952-05

5.  The response of the flicker fusion threshold to nitroglycerin and its potential value in the diagnosis, prognosis, and therapy of subclinical and clinical cardiovascular disease.

Authors:  L R KRASNO; A C IVY
Journal:  Circulation       Date:  1950-06       Impact factor: 29.690

6.  A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort; a study of khellin (visammin).

Authors:  T GREINER; H GOLD; M CATTELL; J TRAVELL; H BAKST; S H RINZLER; Z H BENJAMIN; L J WARSHAW; A L BOBB; N T KWIT; W MODELL; H H ROTHENDLER; C R MESSELOFF; M L KRAMER
Journal:  Am J Med       Date:  1950-08       Impact factor: 4.965

7.  Relative experimental coronary vasodilator potencies of papaverine and its ethyl analogue, ethaverine (diquinol, perparin).

Authors:  C V WINDER; R W THOMAS; O KAMM
Journal:  J Pharmacol Exp Ther       Date:  1950-12       Impact factor: 4.030
  7 in total
  1 in total

1.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1954-07-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.